Ashley Aaroe

605 total citations · 1 hit paper
17 papers, 321 citations indexed

About

Ashley Aaroe is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ashley Aaroe has authored 17 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Ashley Aaroe's work include Glioma Diagnosis and Treatment (11 papers), Brain Metastases and Treatment (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ashley Aaroe is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Brain Metastases and Treatment (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ashley Aaroe collaborates with scholars based in United States, Germany and Canada. Ashley Aaroe's co-authors include Jiyong Liang, Pratibha Sharma, Vinay K. Puduvalli, Hooman Kamel, Iván Díaz, Benjamin Kummer, Babak B. Navi, Costantino Iadecola, Xian Wu and Kathryn Nevel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Ashley Aaroe

14 papers receiving 314 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor microenvironment in glioblastoma: Current and emerging concepts

2023 166 citations Pratibha Sharma, Ashley Aaroe et al. Neuro-Oncology Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley Aaroe United States	6	96	84	80	63	60	17	321
T. Khalil France	9	93 1.0×	78 0.9×	95 1.2×	51 0.8×	86 1.4×	27	345
Jason Adhikaree United Kingdom	6	127 1.3×	107 1.3×	97 1.2×	90 1.4×	111 1.9×	7	330
Francesco Volpin Italy	12	142 1.5×	125 1.5×	69 0.9×	29 0.5×	98 1.6×	21	425
Nicole Colwell United States	6	95 1.0×	110 1.3×	58 0.7×	51 0.8×	22 0.4×	9	319
Guohui Lu China	14	90 0.9×	137 1.6×	43 0.5×	47 0.7×	165 2.8×	32	454
Qibing Huang China	11	66 0.7×	143 1.7×	48 0.6×	56 0.9×	106 1.8×	25	372
Carolina Batista Ariza Brazil	12	98 1.0×	207 2.5×	167 2.1×	126 2.0×	47 0.8×	23	536
Seamus P. Caragher United States	9	189 2.0×	172 2.0×	89 1.1×	52 0.8×	28 0.5×	13	376
Connor J. Stonesifer United States	6	81 0.8×	86 1.0×	61 0.8×	55 0.9×	30 0.5×	17	348
T. Schweitzer Germany	10	74 0.8×	179 2.1×	44 0.6×	51 0.8×	100 1.7×	15	504

Countries citing papers authored by Ashley Aaroe

Since Specialization

Citations

This map shows the geographic impact of Ashley Aaroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Aaroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Aaroe more than expected).

Fields of papers citing papers by Ashley Aaroe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Aaroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Aaroe. The network helps show where Ashley Aaroe may publish in the future.

Co-authorship network of co-authors of Ashley Aaroe

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Aaroe. A scholar is included among the top collaborators of Ashley Aaroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Aaroe. Ashley Aaroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Schumacher, Karl Maria, Soetkin Vlassak, Todd A. Swanson, et al.. (2024). Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion. The Oncologist. 30(1). 1 indexed citations

Aaroe, Ashley, Barbara O’Brien, Nazanin Majd, et al.. (2024). Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study. Neuro-Oncology Practice. 11(4). 475–483. 2 indexed citations

Keam, Synat, Fernanda G. Kugeratski, Anisha B. Patel, et al.. (2024). Toxicity in the era of immune checkpoint inhibitor therapy. Frontiers in Immunology. 15. 1447021–1447021. 27 indexed citations

Majd, Nazanin, D.N. Yeboa, Shuqi Wang, et al.. (2024). Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma.. Journal of Clinical Oncology. 42(16_suppl). 2076–2076. 3 indexed citations

Nasr, Lewis, Clark R. Andersen, Kathryn E. Marqueen, et al.. (2024). Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid Tumors. Advances in Radiation Oncology. 10(2). 101697–101697. 2 indexed citations

Majd, Nazanin, D.N. Yeboa, Shiao‐Pei Weathers, et al.. (2023). CTNI-42. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v84–v84. 1 indexed citations

Sharma, Pratibha, Ashley Aaroe, Jiyong Liang, & Vinay K. Puduvalli. (2023). Tumor microenvironment in glioblastoma: Current and emerging concepts. Neuro-Oncology Advances. 5(1). vdad009–vdad009. 166 indexed citations breakdown →

Weathers, Shiao‐Pei, Carlos Kamiya-Matsuoka, Nazanin Majd, et al.. (2023). CTIM-23. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE ATEZOLIZUMAB IN COMBINATION WITH CABOZANTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v67–v67.

Aaroe, Ashley, Monica Loghin, Jeffrey M. Treiber, et al.. (2023). Leptomeningeal Immunoglobulin G4–Related Disease: A Case Report. SHILAP Revista de lepidopterología. 2(12).

10.

Gregory, Tim, Ashley Aaroe, Barbara O’Brien, et al.. (2023). Analysis of tumor progression among patients with glioma after COVID-19 infection.. Journal of Clinical Oncology. 41(16_suppl). 2041–2041. 3 indexed citations

11.

Aaroe, Ashley, Razelle Kurzrock, Gaurav Goyal, et al.. (2023). Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Advances. 7(15). 3984–3992. 21 indexed citations

12.

Scarffe, Leslie A., et al.. (2023). Neurologic Complications of Cancer Immunotherapy. Current Oncology. 30(6). 5876–5897. 6 indexed citations

13.

Pham, Lily, Karl Maria Schumacher, Soetkin Vlassak, et al.. (2021). INNV-21. COMPLETE RESPONSE TO ADJUVANT TEPOTINIB IN A PATIENT WITH NEWLY DIAGNOSED DISSEMINATED GLIOBLASTOMA (GBM) HARBORING MET AMPLIFICATION. Neuro-Oncology. 23(Supplement_6). vi109–vi109. 3 indexed citations

14.

Aaroe, Ashley, Isabella C. Glitza Oliva, Nagham Al‐Zubidi, et al.. (2021). Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology. 97(5). 248–250. 4 indexed citations

15.

Aaroe, Ashley, Rebecca A. Harrison, Nazanin Majd, et al.. (2020). COVD-30. A SNAPSHOT OF THE IMPACT OF COVID-19 ON PATIENTS WITH NERVOUS SYSTEM TUMORS. Neuro-Oncology. 22(Supplement_2). ii27–ii27. 2 indexed citations

16.

Aaroe, Ashley & Kathryn Nevel. (2019). Central Nervous System Involvement of Natural Killer and T Cell Neoplasms. Current Oncology Reports. 21(5). 40–40. 6 indexed citations

17.

Kummer, Benjamin, Iván Díaz, Xian Wu, et al.. (2019). Associations between cerebrovascular risk factors and parkinson disease. Annals of Neurology. 86(4). 572–581. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact